Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy

for
B-ALL, Hematologic Malignancy, Solid Tumor
Location: Philadelphia PA, Milwaukee WI, Memphis TN, Aurora CO,
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0 - 30

Code: NCT06579469

Recruiting

A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial

for
Malignant Solid Neoplasm
Location: Vancouver WA, Longview WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT06771739

Recruiting

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

for
Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm,
Location: Riverhead NY, Patchogue NY, Port Jefferson Station NY,
Sponsor: BriaCell Therapeutics Corporation

Sex: All

Age: 18+

Code: NCT06072612

Phase 3, Recruiting

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

for
Head and Neck Squamous Cell Carcinoma (HNSCC),
Location: Columbus OH, Grand Rapids MI, Houston TX,
Sponsor: Tanabe Pharma America, Inc.

Sex: All

Age: 18+

Code: NCT06943521

Phase 1, Phase 2, Recruiting

Aromatherapy Essential Oils to Manage Anxiety and Nausea in Cancer Patients Receiving Infusion in the Ambulatory Setting

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Irvine CA, Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07126301

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors

for
Solid Tumors
Location: New York NY, Jacksonville FL, Rochester MN, Houston TX,
Sponsor: Fortvita Biologics (USA)Inc.

Sex: All

Age: 18 - 70+

Code: NCT06963281

Phase 1, Recruiting

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Brewer ME, Boston MA, Providence RI, West Haven CT,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 0+

Code: NCT04242095

Recruiting

Safety and Preliminary Efficacy of VIR-5525 and VIR-5525 + Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

for
Solid Tumor Malignancies, EGFR Positive Solid Tumors, EGFR
Location: Houston TX, Scottsdale AZ
Sponsor: Vir Biotechnology, Inc.

Sex: All

Age: 18+

Code: NCT06960395

Phase 1, Recruiting

Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.

for
Metastases, Metastatic Cancer
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 12+

Code: NCT07594431

Phase 2, Recruiting

Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)

for
Metastatic Cancer, Cervical Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05475171

Phase 2, Recruiting

Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Liquid Molecular Testing Panel in the Community Setting ("DINOSAur II")

for
Stage III Solid Tumors, Stage IV Solid Tumors
Location: Glendale CA
Sponsor: Glendale Adventist Medical Center d/b/a Adventist Health Glendale

Sex: All

Age: 18+

Code: NCT05703243

Recruiting

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors

for
Advanced HR+/HER2- Breast Cancer,
Location: Boston MA, New York NY, Montreal, Toronto,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06726148

Phase 1, Phase 2, Recruiting

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

for
Neoplasms
Location: Boston MA, North Worcester MA, New Haven CT,
Sponsor: Celgene

Sex: All

Age: 0+

Code: NCT03435796

Phase 2, Phase 3, Recruiting

A Study of AWT020 in Participants With Advanced Solid Tumors

for
Advanced Cancers (Solid Tumors)
Location: Fairfax VA, Plantation FL, Nashville TN
Sponsor: Anwita Biosciences

Sex: All

Age: 18+

Code: NCT07822919

Phase 1, Recruiting

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

for
Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors
Location: Augusta ME, Brewer ME, Rockport ME, Belfast ME,
Sponsor: American Society of Clinical Oncology

Sex: All

Age: 12+

Code: NCT02693535

Phase 2, Recruiting

Genomic Profiling in Cancer Patients

for
Solid Tumors, Hematologic Cancers
Location: Commack NY, Norwalk CT, Uniondale NY, Jamaica NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 0+

Code: NCT01775072

Recruiting

HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor

for
Solid Tumors, Adult
Location: Tamarac FL, Plantation FL, Atlanta GA
Sponsor: Hutchmed

Sex: All

Age: 18+

Code: NCT07396584

Phase 1, Phase 2, Recruiting

Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System

for
Cancer, Cancer Central Nervous System, Cancer Thoracic,
Location: New Haven CT, Pittsburgh PA, Dallas TX, Duarte CA,
Sponsor: RefleXion Medical

Sex: All

Age: 0+

Code: NCT05406167

Recruiting

Project: Every Child for Younger Patients With Cancer

for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 25

Code: NCT02402244

Recruiting

Cannabis Oil for Pain Effectiveness

for
Cancer, Chronic Pain
Location: Hamilton
Sponsor: Aurora Cannabis Inc

Sex: All

Age: 25 - 70

Code: NCT03522467

Phase 2, Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial